What is LDN
Low-dose naltrexone (LDN) has been demonstrated to reduce symptom severity in conditions such as fibromyalgia, Crohn’s disease, multiple sclerosis, and complex regional pain syndrome. We review the evidence that LDN may operate as a novel anti-inflammatory agent in the central nervous system, via action on microglial cells.
Conditions treated
Chronic pain, Hashimoto’s, Parkinson’s disease, Arthritis, Graves’ disease, Alzheimer’s, Ulcerative Colitis, Crohn’s Disease, Psoriasis, Eczema, Neuroinflammation, Sjogren’s Syndrome, Inflammation, Multiple Sclerosis,
Irritable bowel, Celiac disease, Autism, Fibromyalgia, Lupus, Traumatic Brain Injury (TBI), Cancer, HIV/Aids, Lyme Disease, Weight Loss, Animals